Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
about
Risk factors associated with adverse reactions to antituberculosis drugsPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Isoniazid metabolism and hepatotoxicityPharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysisCytochrome P450 2E1 gene polymorphisms/haplotypes and anti-tuberculosis drug-induced hepatitis in a Chinese cohortThe incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patientsMeta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene PolymorphismsDistribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan populationHepatotoxicity during Treatment for Tuberculosis in People Living with HIV/AIDS.Evaluation of cytochrome P4502E1 polymorphisms in healthy adult Western Indians and patients with antituberculous drug-induced hepatotoxicity.CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid.Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Latest advances in predicting DILI in human subjects: focus on biomarkers.GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.Drug-induced liver injury: the role of drug metabolism and transport.Update meta-analysis of the CYP2E1 RsaI/PstI and DraI polymorphisms and risk of antituberculosis drug-induced hepatotoxicity: evidence from 26 studies.Drug metabolism and liver disease: a drug-gene-environment interaction.NAT2 gene diversity and its evolutionary trajectory in the Americas.Antioxidant status and GST gene polymorphisms in antitubercular treatment-induced hepatotoxicity patients.Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes.Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral InfarctionPharmGKB summary: isoniazid pathway, pharmacokinetics.PharmGKB summary: very important pharmacogene information for GSTT1.Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.Slow N-acetyltransferase 2 genotype contributes to anti-tuberculosis drug-induced hepatotoxicity: a meta-analysis.The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.N-acetyltransferase 2, cytochrome P4502E1 and glutathione S-transferase genotypes in antitubercular treatment-induced hepatotoxicity in North Indians.Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.Susceptibility of N-acetyltransferase 2 slow acetylators to antituberculosis drug-induced liver injury: a meta-analysis.Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population.The effect of ageing on isoniazid pharmacokinetics and hepatotoxicity in Fischer 344 rats.
P2860
Q26863380-2528E056-9106-4024-949B-5523986A5E0CQ27011622-C70762BA-0BA0-47E7-94BB-8D8C467E53E2Q28076859-B1375C78-52CF-4DEB-BC56-85148EFC938CQ28484468-9B310F27-033F-4467-8E4B-E5896C343E33Q28486869-D99CD28E-7BEF-4BA4-91C0-613874D59006Q28539060-601134F3-9D72-4DD6-A990-AD050F7425A3Q28542785-56549957-D427-4B32-8F6B-6FA5D8530733Q28547892-67AFA7C3-BF5A-4518-BFC0-FDCAFA3BB8EEQ34986858-18AA2D3B-622E-46AD-840E-43EC2CBE3329Q36058879-BCD260A3-6A84-43F2-9E4F-ACF308ED32DFQ36651440-B3F5E3F0-8927-4EE8-A96B-59724EECB3D0Q36867088-9FF720D0-8DAE-4B99-84CF-DA7F4A8740FAQ37590883-D99931D2-A831-4BCB-B27D-88EFA899B90CQ38045377-93B11EA9-3E0F-4C04-8928-30712189DE31Q38078780-F3B3B4E2-24C7-4C91-A910-0882C6830F68Q38084215-16986CCA-7172-4B95-A3E0-90F01217557FQ38381479-5FCCB27D-D137-4A1E-BFBB-5BBE1C389F10Q39037269-40216E26-02C5-42B8-9162-A98D8E8B7567Q40390254-4E0ECAEC-2B65-4A34-B057-94953AC33394Q40706938-9EAFE4A6-32C2-429F-ACFC-B9BA2272AED4Q41068782-252E9E1A-0685-4A73-962E-56C2DD36B854Q42026631-33942AC6-3286-4535-9DBE-0CA5A88CE47FQ42090708-F0DB6E76-F4FE-4B2B-8554-A780DC3D1559Q42235207-AAE55462-CB79-4462-A4E9-8B27B656B8A5Q42708451-9A09EDBC-A0B4-4960-A842-676097DAEBC1Q43474583-55285D08-5BFA-4F2F-A876-670C7A7248B2Q43567165-A552BF11-2D29-467A-BA5F-EF7316F0AE13Q43754598-E73623BD-2907-4381-A860-9A54E2A5C29FQ45766101-050A2BAE-DF37-4A7D-94FA-8BDB78E290DFQ51325880-DDC4EC48-C56B-4386-9C1A-42E819A79551Q51569750-070E659B-0F1B-4D1E-A52A-5F24D0AEF10CQ53734594-368447E1-C334-42EB-8390-FE0188F2AE03Q55022756-8F3F2F78-F531-46D6-A2B9-E855B7A8D5C9
P2860
Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@en
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@nl
type
label
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@en
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@nl
prefLabel
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@en
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@nl
P2093
P2860
P1476
Genetic polymorphisms of NAT2, ...... itis in Brazilian TB patients.
@en
P2093
Adalberto Rezende Santos
Adriana da Silva Rezende Moreira
Afrânio Lineu Kritski
Antonio Basilio de Miranda
Fernanda Carvalho Queiroz Mello
Ligia Mayumi Kitada Muniz
Pedro Hernan Cabello
Philip Noel Suffys
Raquel Lima de Figueiredo Teixeira
Renata Gomes Morato
P2860
P304
P356
10.1590/S0074-02762011000600011
P577
2011-09-01T00:00:00Z